Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Asawapanumas, Thiti [1 ,2 ,3 ,6 ,7 ]
Chanswangphuwana, Chantiya [1 ,2 ,3 ]
Watanaboonyongcharoen, Phandee [4 ,5 ]
Rojnuckarin, Ponlapat [1 ,2 ,3 ]
Bunworasate, Udomsak [1 ,2 ,3 ]
机构：
[1] Chulalongkorn Univ, Fac Med, Dept Med, Div Hematol, Bangkok, Thailand
[2] King Chulalongkorn Mem Hosp, Bangkok, Thailand
[3] Chulalongkorn Univ, Res Unit Translat Hematol, Bangkok, Thailand
[4] Chulalongkorn Univ, Dept Lab Med, Fac Med, Bangkok, Thailand
[5] King Chulalongkorn Mem Hosp, Transfus Med Unit, Bangkok, Thailand
[6] Chulalongkorn Univ, Fac Med, Dept Med, Div Hematol, Rama IV Rd, Bangkok 10330, Thailand
[7] King Chulalongkorn Mem Hosp, Rama IV Rd, Bangkok 10330, Thailand
来源：
LEUKEMIA RESEARCH REPORTS | 2022年 / 17卷
关键词：
Daratumumab; Pure red cell aplasia; Major ABO-mismatched;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Rituximab for pure red cell aplasia after ABO incompatible allogeneic stem cell transplantation
    De Matteis, S
    Sorà, F
    Laurenti, L
    Chiusolo, P
    Zini, G
    Piccirillo, N
    Farina, G
    Tamani, M
    Leone, G
    Sica, S
    BONE MARROW TRANSPLANTATION, 2004, 33 : S341 - S341
  • [22] Oral High Dose Dexamethasone for Pure Red Cell Aplasia Following ABO-Mismatched Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report
    Sharma, Sanjeev Kumar
    Kumar, Suman
    Agrawal, Narendra
    Mishra, Pravas
    Seth, Tulika
    Mahapatra, Manoranjan
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2015, 31 (02) : 317 - 318
  • [23] Oral High Dose Dexamethasone for Pure Red Cell Aplasia Following ABO-Mismatched Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report
    Sanjeev Kumar Sharma
    Suman Kumar
    Narendra Agrawal
    Pravas Mishra
    Tulika Seth
    Manoranjan Mahapatra
    Indian Journal of Hematology and Blood Transfusion, 2015, 31 : 317 - 318
  • [24] MAJOR AND BIDIRECTIONAL ABO INCOMPATIBILITY POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: PURE RED CELL APLASIA AND TRANSPLANT OUTCOME
    Mallouri, D.
    Sakellari, I.
    Bousiou, Z.
    Abela, E.
    Apostolou, C.
    Yannaki, E.
    Batsis, I.
    Smias, C.
    Sotiropoulos, D.
    Ganidou, M.
    Bamihas, G.
    Anagnostopoulos, A.
    HAEMATOLOGICA, 2014, 99 : 718 - 719
  • [25] Late-onset pure red blood cell aplasia owing to delayed lymphoid engraftment complicating ABO-mismatched hematopoietic stem cell transplantation
    An, WY
    Lie, AKW
    Ma, ESK
    Lau, GKK
    Chan, EC
    Kwong, YL
    TRANSFUSION, 2004, 44 (06) : 946 - 947
  • [26] Successful treatment of a pure red cell aplasia patient following ABO-mismatched hematopoietic stem cell transplantation from a sibling donor with multiple sclerosis
    Tavakoli, Farzaneh
    Mohammadian, Mozhdeh
    Ghorbi, Mahmoud Dehghani
    Shahsavan, Shaghayegh
    Halvachi, Dorsa
    Parkhideh, Sayeh
    Roshandel, Elham
    TRANSPLANT IMMUNOLOGY, 2023, 79
  • [27] Daratumumab in the Management of Red Cell Aplasia Following Allogeneic Hematopoietic Stem Cell Transplantation
    Desai, Nihar
    Viswabandya, Auro
    Kim, Dennis Dong Hwan
    Lipton, Jeffrey H.
    Mattsson, Jonas
    Law, Arjun Datt
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (02) : 310 - 314
  • [28] Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation
    Martino, Rodrigo
    Garcia-Cadenas, Irene
    Esquirol, Albert
    BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 282 - 285
  • [29] Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation
    Rodrigo Martino
    Irene García-Cadenas
    Albert Esquirol
    Bone Marrow Transplantation, 2022, 57 : 282 - 285
  • [30] Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab
    Wu, Clinton
    Manchen, Pete
    Edelman, Ariela
    Husnain, Muhammad
    Katsanis, Emmanuel
    Fuchs, Deborah
    Stephens, Laura
    Khurana, Sharad
    JOURNAL OF HEMATOLOGY, 2023, 12 (06) : 277 - 282
12345